TreeWAS – Variant ID: rs2040704

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
J45.9 Asthma, unspecified	1.000	0.000	0.000
J45 Asthma	0.935	0.065	0.000
J45.0 Predominantly allergic asthma	0.921	0.079	0.000
J45.1 Nonallergic asthma	0.689	0.311	0.000
J45.8 Mixed asthma	0.670	0.329	0.000
J40-J47 Chronic lower respiratory diseases	0.032	0.968	0.000
J44 Other chronic obstructive pulmonary disease	0.026	0.974	0.000
J44.8 Other specified chronic obstructive pulmonary disease	0.024	0.976	0.000
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified	0.024	0.976	0.000
J41 Simple and mucopurulent chronic bronchitis	0.023	0.977	0.000
J42 Unspecified chronic bronchitis	0.022	0.978	0.000
C18.9 Colon, unspecified	0.000	0.979	0.021
J43 Emphysema	0.020	0.980	0.000
J41.8 Mixed simple and mucopurulent chronic bronchitis	0.017	0.983	0.000
J41.1 Mucopurulent chronic bronchitis	0.017	0.983	0.000
J41.0 Simple chronic bronchitis	0.017	0.983	0.000
J43.8 Other emphysema	0.016	0.984	0.000
J43.2 Centrilobular emphysema	0.015	0.985	0.000
J43.1 Panlobular emphysema	0.015	0.985	0.000
J43.0 MacLeod's syndrome	0.015	0.985	0.000
J46 Status asthmaticus	0.013	0.986	0.000
J44.9 Chronic obstructive pulmonary disease, unspecified	0.013	0.987	0.000
C18.3 Hepatic flexure	0.000	0.988	0.012
C18 Malignant neoplasm of colon	0.000	0.988	0.012
C18.2 Ascending colon	0.000	0.990	0.010
C18.8 Overlapping lesion of colon	0.000	0.990	0.010
J43.9 Emphysema, unspecified	0.010	0.990	0.000
C18.5 Splenic flexure	0.000	0.990	0.009
C18.6 Descending colon	0.000	0.991	0.009
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection	0.008	0.992	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.008	0.992	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.008	0.992	0.000
C18.7 Sigmoid colon	0.000	0.992	0.008
T43.3 Phenothiazine antipsychotics and neuroleptics	0.008	0.992	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.008	0.992	0.000
C18.1 Appendix	0.000	0.992	0.008
T43.5 Other and unspecified antipsychotics and neuroleptics	0.008	0.992	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.007	0.993	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.007	0.993	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.007	0.993	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.007	0.993	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.007	0.993	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.007	0.993	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.006	0.993	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.006	0.994	0.000
T43.6 Psychostimulants with abuse potential	0.006	0.994	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.006	0.994	0.000
C18.4 Transverse colon	0.000	0.994	0.006
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.006	0.994	0.000
G58.8 Other specified mononeuropathies	0.006	0.994	0.000
B44.9 Aspergillosis, unspecified	0.006	0.994	0.000
T43.9 Psychotropic drug, unspecified	0.006	0.994	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.006	0.994	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.006	0.994	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.006	0.994	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.006	0.994	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.006	0.994	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.006	0.994	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.006	0.994	0.000
T44.0 Anticholinesterase agents	0.006	0.994	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.006	0.994	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.006	0.994	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.006	0.994	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.006	0.994	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.006	0.994	0.000
T36 Poisoning by systemic antibiotics	0.006	0.994	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.006	0.994	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.006	0.994	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.006	0.994	0.000
T40.6 Other and unspecified narcotics	0.006	0.994	0.000
T40.2 Other opioids	0.006	0.994	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.005	0.994	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.005	0.994	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.005	0.995	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.005	0.995	0.000
M16.0 Primary coxarthrosis, bilateral	0.005	0.995	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.005	0.995	0.000
D22.1 Melanocytic naevi of eyelid, including canthus	0.005	0.995	0.000
T39.1 4-Aminophenol derivatives	0.005	0.995	0.000
T43.2 Other and unspecified antidepressants	0.005	0.995	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.005	0.995	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.005	0.995	0.000
T46.7 Peripheral vasodilators	0.005	0.995	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.005	0.995	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.005	0.995	0.000
T47.0 Histamine H(2)-receptor antagonists	0.005	0.995	0.000
B44 Aspergillosis	0.005	0.995	0.000
T39.0 Salicylates	0.005	0.995	0.000
T50.4 Drugs affecting uric acid metabolism	0.005	0.995	0.000
B95.5 Unspecified streptococcus as the cause of diseases classified to other chapters	0.005	0.995	0.000
C18.0 Caecum	0.000	0.995	0.005
T38.9 Other and unspecified hormone antagonists	0.005	0.995	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.005	0.995	0.000
T38.7 Androgens and anabolic congeners	0.005	0.995	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.005	0.995	0.000
T38.5 Other oestrogens and progestogens	0.005	0.995	0.000
T38.4 Oral contraceptives	0.005	0.995	0.000
T38.2 Antithyroid drugs	0.005	0.995	0.000
T38.0 Glucocorticoids and synthetic analogues	0.005	0.995	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.005	0.995	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.005	0.995	0.000
T45.5 Anticoagulants	0.005	0.995	0.000
T49.9 Topical agent, unspecified	0.005	0.995	0.000
T49.8 Other topical agents	0.005	0.995	0.000
T49.7 Dental drugs, topically applied	0.005	0.995	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.005	0.995	0.000
T49.5 Ophthalmological drugs and preparations	0.005	0.995	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.005	0.995	0.000
T49.3 Emollients, demulcents and protectants	0.005	0.995	0.000
T49.2 Local astringents and local detergents	0.005	0.995	0.000
T49.1 Antipruritics	0.005	0.995	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.005	0.995	0.000
T40.8 Lysergide [LSD]	0.005	0.995	0.000
T40.7 Cannabis (derivatives)	0.005	0.995	0.000
T40.5 Cocaine	0.005	0.995	0.000
T40.3 Methadone	0.005	0.995	0.000
T40.1 Heroin	0.005	0.995	0.000
T40.0 Opium	0.005	0.995	0.000
T45.2 Vitamins, not elsewhere classified	0.005	0.995	0.000
E23.0 Hypopituitarism	0.000	0.995	0.005
T46.1 Calcium-channel blockers	0.005	0.995	0.000
T50.8 Diagnostic agents	0.005	0.995	0.000
T50.7 Analeptics and opioid receptor antagonists	0.005	0.995	0.000
T50.5 Appetite depressants	0.005	0.995	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.005	0.995	0.000
T50.1 Loop [high-ceiling] diuretics	0.005	0.995	0.000
T50.0 Mineralocorticoids and their antagonists	0.005	0.995	0.000
T38.1 Thyroid hormones and substitutes	0.005	0.995	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.005	0.995	0.000
B44.1 Other pulmonary aspergillosis	0.005	0.995	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.005	0.995	0.000
T39.4 Antirheumatics, not elsewhere classified	0.005	0.995	0.000
T39.2 Pyrazolone derivatives	0.005	0.995	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.005	0.995	0.000
T45.8 Other primarily systemic and haematological agents	0.005	0.995	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.005	0.995	0.000
T45.6 Fibrinolysis-affecting drugs	0.005	0.995	0.000
T45.4 Iron and its compounds	0.005	0.995	0.000
T45.3 Enzymes, not elsewhere classified	0.005	0.995	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.004	0.995	0.000
T48.5 Anti-common-cold drugs	0.004	0.995	0.000
T48.4 Expectorants	0.004	0.995	0.000
T48.3 Antitussives	0.004	0.995	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.004	0.995	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.004	0.995	0.000
T48.0 Oxytocic drugs	0.004	0.995	0.000
T45.0 Antiallergic and antiemetic drugs	0.005	0.995	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.004	0.995	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.004	0.995	0.000
T37.5 Antiviral drugs	0.004	0.995	0.000
T37.4 Anthelminthics	0.004	0.995	0.000
T37.3 Other antiprotozoal drugs	0.004	0.995	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.004	0.995	0.000
T37.1 Antimycobacterial drugs	0.004	0.995	0.000
T37.0 Sulphonamides	0.004	0.995	0.000
T41.5 Therapeutic gases	0.004	0.995	0.000
T41.4 Anaesthetic, unspecified	0.004	0.995	0.000
T41.3 Local anaesthetics	0.004	0.995	0.000
T41.2 Other and unspecified general anaesthetics	0.004	0.995	0.000
T41.1 Intravenous anaesthetics	0.004	0.995	0.000
T41.0 Inhaled anaesthetics	0.004	0.995	0.000
T36.9 Systemic antibiotic, unspecified	0.004	0.995	0.000
T36.8 Other systemic antibiotics	0.004	0.995	0.000
T36.7 Antifungal antibiotics, systemically used	0.004	0.995	0.000
T36.6 Rifamycins	0.004	0.995	0.000
T36.5 Aminoglycosides	0.004	0.995	0.000
T36.4 Tetracyclines	0.004	0.995	0.000
T36.3 Macrolides	0.004	0.995	0.000
T36.2 Chloramphenicol group	0.004	0.995	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.004	0.995	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.004	0.995	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.004	0.995	0.000
T47.7 Emetics	0.004	0.995	0.000
T47.6 Antidiarrhoeal drugs	0.004	0.995	0.000
T47.5 Digestants	0.004	0.995	0.000
T47.4 Other laxatives	0.004	0.995	0.000
T47.3 Saline and osmotic laxatives	0.004	0.995	0.000
T47.2 Stimulant laxatives	0.004	0.995	0.000
T36.0 Penicillins	0.004	0.996	0.000
T42.0 Hydantoin derivatives	0.004	0.996	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.004	0.996	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.004	0.996	0.000
N76.0 Acute vaginitis	0.000	0.996	0.004
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.004	0.996	0.000
D22.6 Melanocytic naevi of upper limb, including shoulder	0.004	0.996	0.000
J40 Bronchitis, not specified as acute or chronic	0.004	0.996	0.000
B44.8 Other forms of aspergillosis	0.004	0.996	0.000
B44.7 Disseminated aspergillosis	0.004	0.996	0.000
B44.2 Tonsillar aspergillosis	0.004	0.996	0.000
B44.0 Invasive pulmonary aspergillosis	0.004	0.996	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.004	0.996	0.000
M43.16 Spondylolisthesis (Lumbar region)	0.004	0.996	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.004	0.996	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.004	0.996	0.000
T42.3 Barbiturates	0.004	0.996	0.000
T42.2 Succinimides and oxazolidinediones	0.004	0.996	0.000
T42.1 Iminostilbenes	0.004	0.996	0.000
E23.2 Diabetes insipidus	0.000	0.996	0.004
T47.1 Other antacids and anti-gastric-secretion drugs	0.003	0.996	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.004	0.996	0.000
E23 Hypofunction and other disorders of pituitary gland	0.000	0.997	0.003
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.003	0.997	0.000
B95.4 Other streptococcus as the cause of diseases classified to other chapters	0.003	0.997	0.000
B35-B49 Mycoses	0.003	0.997	0.000
T40.4 Other synthetic narcotics	0.003	0.997	0.000
B37.3 Candidiasis of vulva and vagina	0.003	0.997	0.000
H11.0 Pterygium	0.000	0.997	0.003
H11 Other disorders of conjunctiva	0.000	0.997	0.003
H11.3 Conjunctival haemorrhage	0.000	0.997	0.003
B37.8 Candidiasis of other sites	0.003	0.997	0.000
H11.8 Other specified disorders of conjunctiva	0.000	0.997	0.003
J35.0 Chronic tonsillitis	0.003	0.997	0.000
M23.26 Derangement of meniscus due to old tear or injury (Other and unspecified lateral meniscus)	0.000	0.997	0.003
H11.9 Disorder of conjunctiva, unspecified	0.000	0.997	0.003
B37 Candidiasis	0.003	0.997	0.000
S42.30 Fracture of shaft of humerus (closed)	0.000	0.997	0.003
T50.9 Other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.000	0.997	0.003
E23.1 Drug-induced hypopituitarism	0.000	0.997	0.003
Z96.8 Presence of other specified functional implants	0.003	0.997	0.000
J47 Bronchiectasis	0.003	0.997	0.000
E23.7 Disorder of pituitary gland, unspecified	0.000	0.997	0.003
E27.4 Other and unspecified adrenocortical insufficiency	0.000	0.997	0.003
Z33 Pregnant state, incidental	0.000	0.997	0.003
H11.1 Conjunctival degenerations and deposits	0.000	0.997	0.003
B97.8 Other viral agents as the cause of diseases classified to other chapters	0.003	0.997	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.000	0.997	0.003
N39.4 Other specified urinary incontinence	0.000	0.997	0.003
B48 Other mycoses, not elsewhere classified	0.002	0.997	0.000
B47 Mycetoma	0.002	0.997	0.000
B46 Zygomycosis	0.002	0.997	0.000
B45 Cryptococcosis	0.002	0.997	0.000
B43 Chromomycosis and phaeomycotic abscess	0.002	0.997	0.000
B42 Sporotrichosis	0.002	0.997	0.000
B41 Paracoccidioidomycosis	0.002	0.997	0.000
B40 Blastomycosis	0.002	0.997	0.000
B39 Histoplasmosis	0.002	0.997	0.000
B38 Coccidioidomycosis	0.002	0.997	0.000
B49 Unspecified mycosis	0.002	0.997	0.000
H11.2 Conjunctival scars	0.000	0.997	0.002
B36 Other superficial mycoses	0.002	0.997	0.000
B35 Dermatophytosis	0.002	0.997	0.000
E23.6 Other disorders of pituitary gland	0.000	0.998	0.002
T80.8 Other complications following infusion, transfusion and therapeutic injection	0.002	0.998	0.000
T80.2 Infections following infusion, transfusion and therapeutic injection	0.002	0.998	0.000
B95 Streptococcus and staphylococcus as the cause of diseases classified to other chapters	0.002	0.998	0.000
Z52.4 Kidney donor	0.002	0.998	0.000
B95.3 Streptococcus pneumoniae as the cause of diseases classified to other chapters	0.002	0.998	0.000
D22.2 Melanocytic naevi of ear and external auricular canal	0.002	0.998	0.000
H11.4 Other conjunctival vascular disorders and cysts	0.000	0.998	0.002
M43.1 Spondylolisthesis	0.002	0.998	0.000
D22 Melanocytic naevi	0.002	0.998	0.000
G58 Other mononeuropathies	0.002	0.998	0.000
B37.7 Candidal septicaemia	0.002	0.998	0.000
B37.6 Candidal endocarditis	0.002	0.998	0.000
B37.5 Candidal meningitis	0.002	0.998	0.000
Z89.6 Acquired absence of leg above knee	0.000	0.998	0.002
B37.1 Pulmonary candidiasis	0.002	0.998	0.000
L30.9 Dermatitis, unspecified	0.002	0.998	0.000
Z54.0 Convalescence following surgery	0.000	0.998	0.002
B37.4 Candidiasis of other urogenital sites	0.002	0.998	0.000
B95.2 Streptococcus, group D, as the cause of diseases classified to other chapters	0.002	0.998	0.000
B37.2 Candidiasis of skin and nail	0.002	0.998	0.000
M43.19 Spondylolisthesis (Site unspecified)	0.002	0.998	0.000
G60.0 Hereditary motor and sensory neuropathy	0.000	0.998	0.002
N76.8 Other specified inflammation of vagina and vulva	0.000	0.998	0.002
I27.2 Other secondary pulmonary hypertension	0.002	0.998	0.000
B35.3 Tinea pedis	0.002	0.998	0.000
B38.9 Coccidioidomycosis, unspecified	0.002	0.998	0.000
B38.8 Other forms of coccidioidomycosis	0.002	0.998	0.000
B38.7 Disseminated coccidioidomycosis	0.002	0.998	0.000
B38.4 Coccidioidomycosis meningitis	0.002	0.998	0.000
B38.3 Cutaneous coccidioidomycosis	0.002	0.998	0.000
B38.2 Pulmonary coccidioidomycosis, unspecified	0.002	0.998	0.000
B38.1 Chronic pulmonary coccidioidomycosis	0.002	0.998	0.000
B38.0 Acute pulmonary coccidioidomycosis	0.002	0.998	0.000
B39.9 Histoplasmosis, unspecified	0.002	0.998	0.000
B39.5 Histoplasmosis duboisii	0.002	0.998	0.000
B39.4 Histoplasmosis capsulati, unspecified	0.002	0.998	0.000
B39.3 Disseminated histoplasmosis capsulati	0.002	0.998	0.000
B39.2 Pulmonary histoplasmosis capsulati, unspecified	0.002	0.998	0.000
B39.1 Chronic pulmonary histoplasmosis capsulati	0.002	0.998	0.000
B39.0 Acute pulmonary histoplasmosis capsulati	0.002	0.998	0.000
B40.9 Blastomycosis, unspecified	0.002	0.998	0.000
B40.8 Other forms of blastomycosis	0.002	0.998	0.000
B40.7 Disseminated blastomycosis	0.002	0.998	0.000
B40.3 Cutaneous blastomycosis	0.002	0.998	0.000
B40.2 Pulmonary blastomycosis, unspecified	0.002	0.998	0.000
B40.1 Chronic pulmonary blastomycosis	0.002	0.998	0.000
B40.0 Acute pulmonary blastomycosis	0.002	0.998	0.000
B41.9 Paracoccidioidomycosis, unspecified	0.002	0.998	0.000
B41.8 Other forms of paracoccidioidomycosis	0.002	0.998	0.000
B41.7 Disseminated paracoccidioidomycosis	0.002	0.998	0.000
B41.0 Pulmonary paracoccidioidomycosis	0.002	0.998	0.000
B42.9 Sporotrichosis, unspecified	0.002	0.998	0.000
B42.8 Other forms of sporotrichosis	0.002	0.998	0.000
B42.7 Disseminated sporotrichosis	0.002	0.998	0.000
B42.1 Lymphocutaneous sporotrichosis	0.002	0.998	0.000
B42.0 Pulmonary sporotrichosis	0.002	0.998	0.000
B43.9 Chromomycosis, unspecified	0.002	0.998	0.000
B43.8 Other forms of chromomycosis	0.002	0.998	0.000
B43.2 Subcutaneous phaeomycotic abscess and cyst	0.002	0.998	0.000
B43.1 Phaeomycotic brain abscess	0.002	0.998	0.000
B43.0 Cutaneous chromomycosis	0.002	0.998	0.000
B45.9 Cryptococcosis, unspecified	0.002	0.998	0.000
B45.8 Other forms of cryptococcosis	0.002	0.998	0.000
B45.7 Disseminated cryptococcosis	0.002	0.998	0.000
B45.3 Osseous cryptococcosis	0.002	0.998	0.000
B45.2 Cutaneous cryptococcosis	0.002	0.998	0.000
B45.1 Cerebral cryptococcosis	0.002	0.998	0.000
B45.0 Pulmonary cryptococcosis	0.002	0.998	0.000
B46.9 Zygomycosis, unspecified	0.002	0.998	0.000
B46.8 Other zygomycoses	0.002	0.998	0.000
B46.5 Mucormycosis, unspecified	0.002	0.998	0.000
B46.4 Disseminated mucormycosis	0.002	0.998	0.000
B46.3 Cutaneous mucormycosis	0.002	0.998	0.000
B46.2 Gastro-intestinal mucormycosis	0.002	0.998	0.000
B46.1 Rhinocerebral mucormycosis	0.002	0.998	0.000
B46.0 Pulmonary mucormycosis	0.002	0.998	0.000
B47.9 Mycetoma, unspecified	0.002	0.998	0.000
B47.1 Actinomycetoma	0.002	0.998	0.000
B47.0 Eumycetoma	0.002	0.998	0.000
B48.8 Other specified mycoses	0.002	0.998	0.000
B48.7 Opportunistic mycoses	0.002	0.998	0.000
B48.4 Penicillosis	0.002	0.998	0.000
B48.3 Geotrichosis	0.002	0.998	0.000
B48.2 Allescheriasis	0.002	0.998	0.000
B48.1 Rhinosporidiosis	0.002	0.998	0.000
B48.0 Lobomycosis	0.002	0.998	0.000
B36.8 Other specified superficial mycoses	0.002	0.998	0.000
B36.3 Black piedra	0.002	0.998	0.000
B36.2 White piedra	0.002	0.998	0.000
B36.1 Tinea nigra	0.002	0.998	0.000
B36.0 Pityriasis versicolor	0.002	0.998	0.000
H57.9 Disorder of eye and adnexa, unspecified	0.000	0.998	0.002
L30.8 Other specified dermatitis	0.002	0.998	0.000
B35.9 Dermatophytosis, unspecified	0.002	0.998	0.000
B35.8 Other dermatophytoses	0.002	0.998	0.000
B35.5 Tinea imbricata	0.002	0.998	0.000
B35.4 Tinea corporis	0.002	0.998	0.000
B35.2 Tinea manuum	0.002	0.998	0.000
B35.0 Tinea barbae and tinea capitis	0.002	0.998	0.000
N76 Other inflammation of vagina and vulva	0.000	0.998	0.002
M43.12 Spondylolisthesis (Cervical region)	0.002	0.998	0.000
B36.9 Superficial mycosis, unspecified	0.002	0.998	0.000
B95.8 Unspecified staphylococcus as the cause of diseases classified to other chapters	0.002	0.998	0.000
B35.1 Tinea unguium	0.002	0.998	0.000
N32.0 Bladder-neck obstruction	0.000	0.998	0.002
N76.2 Acute vulvitis	0.000	0.998	0.002
B97 Viral agents as the cause of diseases classified to other chapters	0.002	0.998	0.000
B97.4 Respiratory synctial virus as the cause of diseases classified to other chapters	0.002	0.998	0.000
M43.18 Spondylolisthesis (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M43.15 Spondylolisthesis (Thoracolumbar region)	0.002	0.998	0.000
M43.14 Spondylolisthesis (Thoracic region)	0.002	0.998	0.000
M43.13 Spondylolisthesis (Cervicothoracic region)	0.002	0.998	0.000
M43.11 Spondylolisthesis (Occipito-atlanto-axial region)	0.002	0.998	0.000
M43.10 Spondylolisthesis (Multiple sites in spine)	0.002	0.998	0.000
B35.6 Tinea cruris	0.002	0.998	0.000
Z31.0 Tuboplasty or vasoplasty after previous sterilisation	0.000	0.998	0.002
D22.9 Melanocytic naevi, unspecified	0.002	0.998	0.000
G58.0 Intercostal neuropathy	0.002	0.998	0.000
L43.9 Lichen planus, unspecified	0.000	0.998	0.002
L73.9 Follicular disorder, unspecified	0.002	0.998	0.000
K38.1 Appendicular concretions	0.002	0.998	0.000
N76.5 Ulceration of vagina	0.000	0.998	0.002
Z89.4 Acquired absence of foot and ankle	0.000	0.998	0.002
M88.90 Paget's disease of bone, unspecified (Multiple sites)	0.002	0.998	0.000
D89.2 Hypergammaglobulinaemia, unspecified	0.002	0.998	0.000
E27.2 Addisonian crisis	0.000	0.998	0.002
N76.3 Subacute and chronic vulvitis	0.000	0.998	0.002
E27 Other disorders of adrenal gland	0.000	0.998	0.002
D22.3 Melanocytic naevi of other and unspecified parts of face	0.002	0.998	0.000
C67.6 Ureteric orifice	0.000	0.998	0.002
C67.0 Trigone of bladder	0.000	0.998	0.002
T80 Complications following infusion, transfusion and therapeutic injection	0.002	0.998	0.000
C67.8 Overlapping lesion of bladder	0.000	0.998	0.002
G31.8 Other specified degenerative diseases of nervous system	0.000	0.998	0.002
G58.9 Mononeuropathy, unspecified	0.002	0.998	0.000
H01.0 Blepharitis	0.000	0.998	0.002
R76.8 Other specified abnormal immunological findings in serum	0.002	0.998	0.000
Z85.7 Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues	0.000	0.998	0.002
F20.0 Paranoid schizophrenia	0.002	0.998	0.000
G58.7 Mononeuritis multiplex	0.002	0.998	0.000
L30 Other dermatitis	0.002	0.998	0.000
Z89 Acquired absence of limb	0.000	0.998	0.002
M77.47 Metatarsalgia-Ankle/Foot	0.002	0.998	0.000
B97.6 Parvovirus as the cause of diseases classified to other chapters	0.002	0.998	0.000
B97.5 Reovirus as the cause of diseases classified to other chapters	0.002	0.998	0.000
B97.3 Retrovirus as the cause of diseases classified to other chapters	0.002	0.998	0.000
B97.2 Coronavirus as the cause of diseases classified to other chapters	0.002	0.998	0.000
B97.1 Enterovirus as the cause of diseases classified to other chapters	0.002	0.998	0.000
B97.0 Adenovirus as the cause of diseases classified to other chapters	0.002	0.998	0.000
M82.11 Osteoporosis in endocrine disorders (Shoulder region)	0.000	0.998	0.002
Z49.1 Extracorporeal dialysis	0.002	0.998	0.000
D22.0 Melanocytic naevi of lip	0.002	0.998	0.000
E27.1 Primary adrenocortical insufficiency	0.000	0.998	0.002
N85.8 Other specified noninflammatory disorders of uterus	0.000	0.998	0.002
S00.0 Superficial injury of scalp	0.000	0.998	0.002
I28.8 Other specified diseases of pulmonary vessels	0.002	0.998	0.000
W50.9 Unspecified place	0.000	0.998	0.002
Z89.9 Acquired absence of limb, unspecified	0.000	0.998	0.002
Z89.2 Acquired absence of upper limb above wrist	0.000	0.998	0.002
B37.9 Candidiasis, unspecified	0.002	0.998	0.000
M16.7 Other secondary coxarthrosis	0.002	0.998	0.000
E27.5 Adrenomedullary hyperfunction	0.000	0.998	0.001
E27.0 Other adrenocortical overactivity	0.000	0.998	0.001
N31.8 Other neuromuscular dysfunction of bladder	0.000	0.998	0.002
T80.9 Unspecified complication following infusion, transfusion and therapeutic injection	0.001	0.998	0.000
T80.6 Other serum reactions	0.001	0.998	0.000
T80.5 Anaphylactic shock due to serum	0.001	0.998	0.000
T80.4 Rh incompatibility reaction	0.001	0.998	0.000
T80.3 ABO incompatibility reaction	0.001	0.998	0.000
T80.0 Air embolism following infusion, transfusion and therapeutic injection	0.001	0.998	0.000
Z89.7 Acquired absence of both lower limbs [any level, except toes alone]	0.000	0.998	0.002
F20.9 Schizophrenia, unspecified	0.002	0.998	0.000
O43.8 Other placental disorders	0.002	0.998	0.000
M41.95 Scoliosis, unspecified (Thoracolumbar region)	0.000	0.998	0.002
J99.8 Respiratory disorders in other diseases classified elsewhere	0.002	0.998	0.000
N76.6 Ulceration of vulva	0.000	0.998	0.001
Z36.9 Antenatal screening, unspecified	0.000	0.998	0.002
F20 Schizophrenia	0.002	0.998	0.000
E27.8 Other specified disorders of adrenal gland	0.000	0.998	0.001
E27.9 Disorder of adrenal gland, unspecified	0.000	0.998	0.001
N31.2 Flaccid neuropathic bladder, not elsewhere classified	0.000	0.998	0.002
S72.10 Pertrochanteric fracture (closed)	0.000	0.998	0.002
C67.3 Anterior wall of bladder	0.000	0.998	0.001
F25.9 Schizoaffective disorder, unspecified	0.001	0.998	0.000
L30.5 Pityriasis alba	0.001	0.998	0.000
L30.4 Erythema intertrigo	0.001	0.998	0.000
L30.3 Infective dermatitis	0.001	0.998	0.000
L30.2 Cutaneous autosensitisation	0.001	0.998	0.000
L30.1 Dyshidrosis [pompholyx]	0.001	0.998	0.000
L30.0 Nummular dermatitis	0.001	0.998	0.000
N76.1 Subacute and chronic vaginitis	0.000	0.998	0.001
Z89.8 Acquired absence of upper and lower limbs [any level]	0.000	0.998	0.001
Z89.5 Acquired absence of leg at or below knee	0.000	0.998	0.001
Z89.3 Acquired absence of both upper limbs [any level]	0.000	0.998	0.001
Z89.1 Acquired absence of hand and wrist	0.000	0.998	0.001
C67 Malignant neoplasm of bladder	0.000	0.998	0.002
I05.9 Mitral valve disease, unspecified	0.001	0.998	0.000
M88.99 Paget's disease of bone, unspecified (Site unspecified)	0.001	0.999	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.000	0.999	0.001
F33.9 Recurrent depressive disorder, unspecified	0.001	0.999	0.000
K12.1 Other forms of stomatitis	0.000	0.999	0.001
K83.8 Other specified diseases of biliary tract	0.001	0.999	0.000
M88.9 Paget's disease of bone, unspecified	0.001	0.999	0.000
T80.1 Vascular complications following infusion, transfusion and therapeutic injection	0.001	0.999	0.000
E46 Unspecified protein-energy malnutrition	0.000	0.999	0.001
J35 Chronic diseases of tonsils and adenoids	0.001	0.999	0.000
E04.9 Non-toxic goitre, unspecified	0.000	0.999	0.001
H54.7 Unspecified visual loss	0.001	0.999	0.000
K59.8 Other specified functional intestinal disorders	0.000	0.999	0.001
J35.2 Hypertrophy of adenoids	0.001	0.999	0.000
F20.8 Other schizophrenia	0.001	0.999	0.000
F20.6 Simple schizophrenia	0.001	0.999	0.000
F20.5 Residual schizophrenia	0.001	0.999	0.000
F20.4 Postschizophrenic depression	0.001	0.999	0.000
F20.3 Undifferentiated schizophrenia	0.001	0.999	0.000
F20.2 Catatonic schizophrenia	0.001	0.999	0.000
F20.1 Hebephrenic schizophrenia	0.001	0.999	0.000
L94.0 Localised scleroderma [morphea]	0.001	0.999	0.000
S42.3 Fracture of shaft of humerus	0.000	0.999	0.001
I82.8 Embolism and thrombosis of other specified veins	0.001	0.999	0.000
A46 Erysipelas	0.001	0.999	0.000
M86.97 Osteomyelitis, unspecified (Ankle and foot)	0.000	0.999	0.001
B97.7 Papillomavirus as the cause of diseases classified to other chapters	0.001	0.999	0.000
H83.0 Labyrinthitis	0.001	0.999	0.000
J98.9 Respiratory disorder, unspecified	0.001	0.999	0.000
F25 Schizoaffective disorders	0.001	0.999	0.000
M41.90 Scoliosis, unspecified (Multiple sites in spine)	0.000	0.999	0.001
C67.7 Urachus	0.000	0.999	0.001
D73.4 Cyst of spleen	0.001	0.999	0.000
G80.9 Infantile cerebral palsy, unspecified	0.001	0.999	0.000
Z94.7 Corneal transplant status	0.001	0.999	0.000
B95-B98 Bacterial, viral and other infectious agents	0.001	0.999	0.000
M19.92 Arthrosis, unspecified (Upper arm)	0.001	0.999	0.000
M88.98 Paget's disease of bone, unspecified (Other)	0.001	0.999	0.000
M88.97 Paget's disease of bone, unspecified (Ankle and foot)	0.001	0.999	0.000
M88.96 Paget's disease of bone, unspecified (Lower leg)	0.001	0.999	0.000
M88.95 Paget's disease of bone, unspecified (Pelvic region and thigh)	0.001	0.999	0.000
M88.94 Paget's disease of bone, unspecified (Hand)	0.001	0.999	0.000
M88.93 Paget's disease of bone, unspecified (Forearm)	0.001	0.999	0.000
M88.92 Paget's disease of bone, unspecified (Upper arm)	0.001	0.999	0.000
M88.91 Paget's disease of bone, unspecified (Shoulder region)	0.001	0.999	0.000
C67.5 Bladder neck	0.000	0.999	0.001
K38.8 Other specified diseases of appendix	0.001	0.999	0.000
C67.2 Lateral wall of bladder	0.000	0.999	0.001
C77.8 Lymph nodes of multiple regions	0.000	0.999	0.001
F25.1 Schizoaffective disorder, depressive type	0.001	0.999	0.000
I83.0 Varicose veins of lower extremities with ulcer	0.000	0.999	0.001
J35.3 Hypertrophy of tonsils with hypertrophy of adenoids	0.001	0.999	0.000
T82.8 Other complications of cardiac and vascular prosthetic devices, implants and grafts	0.001	0.999	0.000
M43.17 Spondylolisthesis (Lumbosacral region)	0.001	0.999	0.000
C67.1 Dome of bladder	0.000	0.999	0.001
M41.9 Scoliosis, unspecified	0.000	0.999	0.001
A16.2 Tuberculosis of lung, without mention of bacteriological or histological confirmation	0.001	0.999	0.000
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia	0.001	0.999	0.000
T17.9 Foreign body in respiratory tract, part unspecified	0.001	0.999	0.000
M41.94 Scoliosis, unspecified (Thoracic region)	0.000	0.999	0.001
Z94.3 Heart and lungs transplant status	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations